NCT06162650View on ClinicalTrials.gov

Total Neoadjuvant Therapy in Rectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

November 16, 2026

Study Completion Date

November 16, 2030

Conditions
Rectal Cancer
Interventions
RADIATION

Short-course radiotherapy

Short-course radiotherapy, 5×5 Gy.

DRUG

mFOLFOX6

Oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, infusinal 5-fluorouracil 2400 mg/m2 every 2 weeks, for 9 cycles

Trial Locations (1)

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER